SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* WEGLICKI TIMOTHY T (Last) (First) (Middle) 400 EAST PRATT STREET SUITE 910 (Street) BALTIMORE MD 21202 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol COVENTRY HEALTH CARE INC [ CVH ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 06/26/2008
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/26/2008		P		1,300	A	$31	57,312(1)	D(2)
Common Stock	06/26/2008		P		900	A	$30.99	58,212(3)	D(4)
Common Stock	06/26/2008		P		300	A	$30.98	58,512(5)	D(6)
Common Stock	06/26/2008		P		200	A	$30.97	58,712(7)	D(8)
Common Stock	06/26/2008		P		100	A	$30.96	58,812(9)	D(10)
Common Stock	06/26/2008		P		100	A	$30.95	58,912(11)	D(12)
Common Stock	06/26/2008		P		500	A	$30.94	59,412(13)	D(14)
Common Stock	06/26/2008		P		400	A	$30.92	59,812(15)	D(16)
Common Stock	06/26/2008		P		100	A	$30.9	59,912(17)	D(18)
Common Stock	06/26/2008		P		100	A	$30.85	60,012(19)	D(20)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes the following: Table I-Non-Derivative Securities comprised of 12,550 shares of common stock held directly, 1,125 shares of common stock held indirectly by spouse, and 15,075 shares of restricted common stock held directly and vesting over three year periods; Table II-Derivative Securities comprised of 23,430 stock options vesting in equal annual increments over three year periods, and 5,132 restricted stock units vesting quarterly over one year periods and held through Coventry's Deferred Compensation Plan for Non-Employee Directors.

2. See Footnote 1 for shares directly and indirectly.

3. Includes the following: Table I-Non-Derivative Securities comprised of 13,450 shares of common stock held directly, 1,125 shares of common stock held indirectly by spouse, and 15,075 shares of restricted common stock held directly and vesting over three year periods; Table II-Derivative Securities comprised of 23,430 stock options vesting in equal annual increments over three year periods, and 5,132 restricted stock units vesting quarterly over one year periods and held through Coventry's Deferred Compensation Plan for Non-Employee Directors.

4. See Footnote 3 for shares held directly and indirectly.

5. Includes the following: Table I-Non-Derivative Securities comprised of 13,750 shares of common stock held directly, 1,125 shares of common stock held indirectly by spouse, and 15,075 shares of restricted common stock held directly and vesting over three year periods; Table II-Derivative Securities comprised of 23,430 stock options vesting in equal annual increments over three year periods, and 5,132 restricted stock units vesting quarterly over one year periods and held through Coventry's Deferred Compensation Plan for Non-Employee Directors.

6. See Footnote 5 for shares held directly and indirectly.

7. Includes the following: Table I-Non-Derivative Securities comprised of 13,950 shares of common stock held directly, 1,125 shares of common stock held indirectly by spouse, and 15,075 shares of restricted common stock held directly and vesting over three year periods; Table II-Derivative Securities comprised of 23,430 stock options vesting in equal annual increments over three year periods, and 5,132 restricted stock units vesting quarterly over one year periods and held through Coventry's Deferred Compensation Plan for Non-Employee Directors.

8. See Footnote 7 for shares held directly and indirectly.

9. Includes the following: Table I-Non-Derivative Securities comprised of 14,050 shares of common stock held directly, 1,125 shares of common stock held indirectly by spouse, and 15,075 shares of restricted common stock held directly and vesting over three year periods; Table II-Derivative Securities comprised of 23,430 stock options vesting in equal annual increments over three year periods, and 5,132 restricted stock units vesting quarterly over one year periods and held through Coventry's Deferred Compensation Plan for Non-Employee Directors.

10. See Footnote 9 for shares held directly and indirectly.

11. Includes the following: Table I-Non-Derivative Securities comprised of 14,150 shares of common stock held directly, 1,125 shares of common stock held indirectly by spouse, and 15,075 shares of restricted common stock held directly and vesting over three year periods; Table II-Derivative Securities comprised of 23,430 stock options vesting in equal annual increments over three year periods, and 5,132 restricted stock units vesting quarterly over one year periods and held through Coventry's Deferred Compensation Plan for Non-Employee Directors.

12. For shares held directly and indirectly.

13. Includes the following: Table I-Non-Derivative Securities comprised of 14,650 shares of common stock held directly, 1,125 shares of common stock held indirectly by spouse, and 15,075 shares of restricted common stock held directly and vesting over three year periods; Table II-Derivative Securities comprised of 23,430 stock options vesting in equal annual increments over three year periods, and 5,132 restricted stock units vesting quarterly over one year periods and held through Coventry's Deferred Compensation Plan for Non-Employee Directors.

14. See Footnote 13 for shares held directly and indirectly.

15. Includes the following: Table I-Non-Derivative Securities comprised of 15,050 shares of common stock held directly, 1,125 shares of common stock held indirectly by spouse, and 15,075 shares of restricted common stock held directly and vesting over three year periods; Table II-Derivative Securities comprised of 23,430 stock options vesting in equal annual increments over three year periods, and 5,132 restricted stock units vesting quarterly over one year periods and held through Coventry's Deferred Compensation Plan for Non-Employee Directors.

16. See Footnote 15 for shares directly and indirectly.

17. Includes the following: Table I-Non-Derivative Securities comprised of 15,150 shares of common stock held directly, 1,125 shares of common stock held indirectly by spouse, and 15,075 shares of restricted common stock held directly and vesting over three year periods; Table II-Derivative Securities comprised of 23,430 stock options vesting in equal annual increments over three year periods, and 5,132 restricted stock units vesting quarterly over one year periods and held through Coventry's Deferred Compensation Plan for Non-Employee Directors.

18. See Footnote 17 for shares held directly and indirectly.

19. Includes the following: Table I-Non-Derivative Securities comprised of 15,250 shares of common stock held directly, 1,125 shares of common stock held indirectly by spouse, and 15,075 shares of restricted common stock held directly and vesting over three year periods; Table II-Derivative Securities comprised of 23,430 stock options vesting in equal annual increments over three year periods, and 5,132 restricted stock units vesting quarterly over one year periods and held through Coventry's Deferred Compensation Plan for Non-Employee Directors.

20. See Footnote 19 for shares held directly and indirectly.

	Shirley R. Smith on behalf of Timothy T. Weglicki by Power of Attorney	06/30/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.